DaVita Inc. (DVA)

Market Cap	13.23B
Revenue (ttm)	12.67B
Net Income (ttm)	827.68M
Shares Out	82.00M
EPS (ttm)	9.24
PE Ratio	17.46
Forward PE	14.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	998,184
Open	157.12
Previous Close	156.98
Day's Range	156.86 - 161.89
52-Week Range	97.31 - 168.50
Beta	0.89
Analysts	Hold
Price Target	153.40 (-4.96%)
Earnings Date	Oct 29, 2024

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 70,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA
• Website: https://www.davita.com

Financial Performance

In 2023, DaVita's revenue was $12.14 billion, an increase of 4.57% compared to the previous year's $11.61 billion. Earnings were $691.54 million, an increase of 23.40%.

Analyst Forecast

According to 5 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $153.4, which is a decrease of -4.96% from the latest price.

Price Target

$153.4

(-4.96% downside)

Analyst Consensus: Hold